Stocks
AnaptysBio (ANAB) Debt/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Debt/EBITDA | 9.46 | 4.01 | 2.39 | 0.17 | -4.30 | -0.17 | ||
| Changes by years, y/y, % | -53% | -58% | -40% | -93% | -2 605% | |||
AnaptysBio. Debt/EBITDA
AnaptysBio. Debt/EBITDA, changes, %
AnaptysBio (ANAB) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| Debt/EBITDA | 4.20 | -21.3 | -0.30 | -0.16 | -1.05 | -0.17 | ||
| Changes by years, y/y, % | +75% | -737% | -108% | -104% | -125% | |||
| Changes by quarters, q/q, % | -1% | -608% | -99% | -49% | +575% | |||
